Страна: Новая Зеландия
Язык: английский
Источник: Ministry for Primary Industries
enrofloxacin
Elanco New Zealand
enrofloxacin
enrofloxacin 25 g/litre
Antibiotic
ACVM Registered
2010-07-20
PACK INSERT Issue Date: 14-10-2023 Page: 1 of 13 _The information above this line is not included in the label _ RESTRICTED VETERINARY MEDICINE KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY BAYTRIL 25 FLAVOUR ANTIBACTERIAL ORAL SUSPENSION DESCRIPTION: Enrofloxacin is a synthetic drug from the class of the quinolone carboxylic acid derivatives, also known as fluoroquinolones. It has antibacterial activity against a broad spectrum of gram negative and gram positive bacteria, including Mycoplasma. (See Table 1). It is rapidly absorbed from the digestive tract, penetrating into all measured body tissues and fluids (See Table 2). Enrofloxacin has the chemical name 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1, 4-dihydro-4- oxo-3-quinolinecarboxylic acid. MICROBIOLOGY: Enrofloxacin exerts bactericidal activity by interaction with the A subunit of DNA gyrase in the target bacteria. The DNA gyrase is a topoisomerase which controls bacterial replication, i.e., it catalyses supercoiling by rewinding and rejoining of chromosomal DNA strands. The fluoroquinolones also possess activity against bacteria in the stationary phase by an alteration of the permeability of the outer membrane phospholipid layer of the cell wall. These mechanisms of action explain the rapid loss of viability of susceptible bacteria. With enrofloxacin, inhibitory and bactericidal concentrations are closely correlated. They are identical or differ in many cases within one or two dilution steps at maximum. Enrofloxacin possesses antimicrobial activity at low concentration against most gram negative bacteria, many gram positive bacteria and against mycoplasmas. Enrofloxacin is therefore active against the micro-organisms that are primarily or secondarily involved in many of the infectious diseases which occur in small animals. PACK INSERT - CONTINUED Issue Date: 14-10-2023 Page: 2 of 13 _The information above this line is not included in the label _ TABLE 1. Minimum Inhibitory Concentrations for enrofloxacin against pathogens isolated from d Прочитать полный документ